Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate ... representative in the GLP-1 agonist market to testify at the hearing. AstraZeneca's run of positive ...

Norvo Nordisk (NVO) (OTCPK ... after the Danish pharma giant’s CEO agreed to testify before the Senate later this year. Sen. Bernie Sanders (I-Vt.), the chairman of the Senate Committee on ...

Now, Novo Nordisk CEO Lars Fruergaard Jørgensen has volunteered to testify to the U.S. Senate to defend the massive markup ...

Novo Nordisk's (NVO) investors are worried its competition ... according to the latest prescription data last month. But Novo CEO Lars Jørgensen attributes the softness in sales to the copycats ...

estimates of $0.94). Revenue figures came out to a total of $11.9 billion, falling in line with Wall Street estimates. Novo Nordisk CEO Lars Jørgensen sits down for an interview with Yahoo Finance ...

Novo Nordisk's (NVO) investors are worried its competition with ... according to the latest prescription data last month. But Novo CEO Lars Jørgensen attributes the softness in sales to the copycats ...